US 11739101
Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof
granted A61PA61P31/12A61P35/00
Quick answer
US patent 11739101 (Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof) held by NURIX THERAPEUTICS, INC. expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- NURIX THERAPEUTICS, INC.
- Grant date
- Tue Aug 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 40
- CPC classes
- A61P, A61P31/12, A61P35/00, A61P37/02